154 related articles for article (PubMed ID: 32945456)
1. CD9 knockdown suppresses cell proliferation, adhesion, migration and invasion, while promoting apoptosis and the efficacy of chemotherapeutic drugs and imatinib in Ph+ ALL SUP‑B15 cells.
Xing C; Xu W; Shi Y; Zhou B; Wu D; Liang B; Zhou Y; Gao S; Feng J
Mol Med Rep; 2020 Oct; 22(4):2791-2800. PubMed ID: 32945456
[TBL] [Abstract][Full Text] [Related]
2. Interaction between CD9 and PI3K‑p85 activates the PI3K/AKT signaling pathway in B‑lineage acute lymphoblastic leukemia.
Shi YF; Huang ZY; Huang YS; Dong RJ; Xing CY; Yu K; Leung KT; Feng JH
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036396
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of CD19 expression inhibits proliferation, adhesion, migration and invasion and promotes apoptosis and the efficacy of chemotherapeutic agents and imatinib in SUP-B15 cells.
Wu J; Liang B; Qian Y; Tang L; Xing C; Zhuang Q; Shen Z; Jiang S; Yu K; Feng J
Cell Biol Int; 2018 Sep; 42(9):1228-1239. PubMed ID: 29809305
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
[TBL] [Abstract][Full Text] [Related]
5. Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN.
Wang WZ; Lin XH; Pu QH; Liu MY; Li L; Wu LR; Wu QQ; Mao JW; Zhu JY; Jin XB
Biochem Biophys Res Commun; 2014 Nov; 454(3):423-8. PubMed ID: 25451263
[TBL] [Abstract][Full Text] [Related]
6. Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.
Guo Y; Shan Q; Gong Y; Lin J; Yang X; Zhou R
Cancer Biol Ther; 2012 Nov; 13(13):1244-54. PubMed ID: 22895079
[TBL] [Abstract][Full Text] [Related]
7. Huaier extract enhances the treatment efficacy of imatinib in Ik6
Qu P; Han J; Qiu Y; Yu H; Hao J; Jin R; Zhou F
Biomed Pharmacother; 2019 Sep; 117():109071. PubMed ID: 31202171
[TBL] [Abstract][Full Text] [Related]
8. CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
Arnaud MP; Vallée A; Robert G; Bonneau J; Leroy C; Varin-Blank N; Rio AG; Troadec MB; Galibert MD; Gandemer V
Blood; 2015 Oct; 126(15):1802-12. PubMed ID: 26320102
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
10. CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity.
Leung KT; Zhang C; Chan KYY; Li K; Cheung JTK; Ng MHL; Zhang XB; Sit T; Lee WYW; Kang W; To KF; Yu JWS; Man TKF; Wang H; Tsang KS; Cheng FWT; Lam GKS; Chow TW; Leung AWK; Leung TF; Yuen PMP; Ng PC; Li CK
Leukemia; 2020 Mar; 34(3):709-720. PubMed ID: 31624373
[TBL] [Abstract][Full Text] [Related]
11. CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells.
Okamoto T; Iwata S; Yamazaki H; Hatano R; Komiya E; Dang NH; Ohnuma K; Morimoto C
PLoS One; 2014; 9(1):e86671. PubMed ID: 24466195
[TBL] [Abstract][Full Text] [Related]
12. RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.
Masuda T; Maeda S; Shimada S; Sakuramoto N; Morita K; Koyama A; Suzuki K; Mitsuda Y; Matsuo H; Kubota H; Kato I; Tanaka K; Takita J; Hirata M; Kataoka TR; Nakahata T; Adachi S; Hirai H; Mizuta S; Naka K; Imai Y; Kimura S; Sugiyama H; Kamikubo Y
Cancer Sci; 2022 Feb; 113(2):529-539. PubMed ID: 34902205
[TBL] [Abstract][Full Text] [Related]
13. CD9 regulates keratinocyte differentiation and motility by recruiting E-cadherin to the plasma membrane and activating the PI3K/Akt pathway.
Jiang X; Teng M; Ji R; Zhang D; Zhang Z; Lv Y; Zhang Q; Zhang J; Huang Y
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118574. PubMed ID: 31682865
[TBL] [
